Pharmacokinetics, safety, and antiviral effects of hypericin, a derivative of St. John's wort plant, in patients with chronic hepatitis C virus infection.
about
Hypericin in the Light and in the Dark: Two Sides of the Same CoinAntimicrobial and antioxidant activities of the extracts and compounds from the leaves of Psorospermum aurantiacum Engl. and Hypericum lanceolatum Lam.Reduction in hypericin-induced phototoxicity by Hypericum perforatum extracts and pure compounds.Undeclared exposure to St. John's Wort in hospitalized patientsSubdiffraction localization of a nanostructured photosensitizer in bacterial cells.Biliary and duodenal drainage for reducing the radiotoxic risk of antineoplastic 131I-hypericin in rat modelsFactors affecting polyphenol biosynthesis in wild and field grown St. John's Wort (Hypericum perforatum L. Hypericaceae/Guttiferae).Hypericum in infection: Identification of anti-viral and anti-inflammatory constituents.Crinoids: ancient organisms, modern chemistry.Bioactive compounds from Hypericum humifusum and Hypericum perfoliatum: inhibition potential of polyphenols with acetylcholinesterase and key enzymes linked to type-2 diabetes.Lower sensitivity of FHC fetal colon epithelial cells to photodynamic therapy compared to HT-29 colon adenocarcinoma cells despite higher intracellular accumulation of hypericin.Necrosis predominates in the cell death of human colon adenocarcinoma HT-29 cells treated under variable conditions of photodynamic therapy with hypericin.Evaluation of traditional medicines II: the use of metabolite peak-kinetics to monitor PHELA in rat plasma.Investigating the effectiveness of St John's wort herb as an antimicrobial agent against mycobacteria.Effect of oral administration ofHypericum perforatum extract (St. John's Wort) on skin erythema and pigmentation induced by UVB, UVA, visible light and solar simulated radiation.Necrosis affinity evaluation of 131I-hypericin in a rat model of induced necrosis.Biodistribution and tolerance of intravenous iodine-131-labelled hypericin in healthy dogs.Effective inactivation of food pathogens Listeria monocytogenes and Salmonella enterica by combined treatment of hypericin-based photosensitization and high power pulsed light.Effects of polysaccharide elicitors on secondary metabolite production and antioxidant response in Hypericum perforatum L. shoot cultures.A phase 1/2 study of orally administered synthetic hypericin for treatment of recurrent malignant gliomas.
P2860
Q26747362-2BEA2C76-6853-43F6-97E6-44F670533C57Q34391974-69CACF0E-A2DE-4DCC-ACA4-B7111879AEC2Q35103698-4F2E2277-5BD9-4013-8CD6-5F0BF2323802Q35826380-71062105-B12C-4B60-B15E-B0A52A50F073Q36192616-5EA18F5F-F7C6-4F17-BD00-B19986E007B5Q37071343-BBCA6A58-A97F-466C-9EA9-5640E4CCA2FEQ37391965-53DD8335-B322-4DA9-893F-21121365321FQ37415644-DD4508D6-1559-4026-AF68-E57BFC509D36Q38867920-5DBECF9F-F353-49B3-8138-89E979404DFAQ38986030-EC07E645-7F36-48F8-96CB-190E5F9FC12DQ39596935-B4C2D143-0E3F-4549-A463-E79299117D67Q40111867-FDAA0365-5E7B-4E89-AEE4-01A99837396EQ42249616-A0553054-9169-449D-87D6-A360D1723043Q42721746-9BF78105-3650-4835-9E86-C6B0BAE7AF8BQ44325237-51EE0FB5-46D0-4F8F-B97C-58FCD4E7253CQ44452260-4F0EC850-6B72-473A-BD22-74E60FCA97B0Q48286237-1CDFB6A8-0910-46F4-9743-6CC57EB09EBCQ50027596-55D289AA-7BB5-4862-9005-FB82F85DF595Q55387030-A010EFFE-5AC1-4098-9727-6DC3C7EC2870Q55463279-CC5355F5-D012-41D9-B3A1-3D32B3006542
P2860
Pharmacokinetics, safety, and antiviral effects of hypericin, a derivative of St. John's wort plant, in patients with chronic hepatitis C virus infection.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pharmacokinetics, safety, and ...... c hepatitis C virus infection.
@ast
Pharmacokinetics, safety, and ...... c hepatitis C virus infection.
@en
type
label
Pharmacokinetics, safety, and ...... c hepatitis C virus infection.
@ast
Pharmacokinetics, safety, and ...... c hepatitis C virus infection.
@en
prefLabel
Pharmacokinetics, safety, and ...... c hepatitis C virus infection.
@ast
Pharmacokinetics, safety, and ...... c hepatitis C virus infection.
@en
P2093
P2860
P1476
Pharmacokinetics, safety, and ...... c hepatitis C virus infection.
@en
P2093
A M Prince
B E Cabana
J M Jacobson
J Spritzler
V Koslowski
P2860
P304
P356
10.1128/AAC.45.2.517-524.2001
P407
P577
2001-02-01T00:00:00Z